SELT expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.22120000001225E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.94119999963327E-07 |
Normal-vs-Stage2 |
7.633900E-02 |
Normal-vs-Stage3 |
7.8251999990897E-08 |
Normal-vs-Stage4 |
1.09569999962034E-07 |
Stage1-vs-Stage2 |
1.912000E-01 |
Stage1-vs-Stage3 |
1.982040E-01 |
Stage1-vs-Stage4 |
4.244200E-01 |
Stage2-vs-Stage3 |
5.790300E-02 |
Stage2-vs-Stage4 |
9.436300E-02 |
Stage3-vs-Stage4 |
6.623600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.92920000039199E-07 |
Normal-vs-AfricanAmerican |
5.88469999951435E-07 |
Normal-vs-Asian |
3.195700E-02 |
Caucasian-vs-AfricanAmerican |
4.401600E-01 |
Caucasian-vs-Asian |
8.762200E-01 |
AfricanAmerican-vs-Asian |
9.302600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.56860000438886E-08 |
Normal-vs-Female |
1.74259999985438E-07 |
Male-vs-Female |
3.919800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.806960E-04 |
Normal-vs-Age(41-60Yrs) |
5.22649999945557E-07 |
Normal-vs-Age(61-80Yrs) |
7.72829999995395E-07 |
Normal-vs-Age(81-100Yrs) |
4.475600E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.490200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.375600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.884000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.408800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.051600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.225800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.714300E-02 |
Normal-vs-Grade 2 |
1.7531699999962E-05 |
Normal-vs-Grade 3 |
3.29879457083848E-11 |
Normal-vs-Grade 4 |
3.94900000477705E-08 |
Grade 1-vs-Grade 2 |
9.246000E-01 |
Grade 1-vs-Grade 3 |
3.388200E-01 |
Grade 1-vs-Grade 4 |
2.957400E-01 |
Grade 2-vs-Grade 3 |
4.379600E-02 |
Grade 2-vs-Grade 4 |
5.793800E-02 |
Grade 3-vs-Grade 4 |
6.531800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.62489999999682E-06 |
Normal-vs-ccB subtype |
5.98800000000121E-05 |
ccA subtype-vs-ccB subtype |
6.544000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.06039999999241E-05 |
Normal-vs-N1 |
2.488500E-02 |
N0-vs-N1 |
9.795400E-01 |
|
|